NYSE: RMD
Resmed Inc Stock Ownership - Who owns Resmed?

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael J. FarrellCEO;Chair2026-10-074,991$146.34
$730.38kBuy
Michael J. FarrellCEO;Chair2026-10-074,991$226.34
$1.13MSell
Michael J. FarrellCEO;Chair2026-09-084,991$146.34
$730.38kBuy
Michael J. FarrellCEO;Chair2026-09-084,991$222.44
$1.11MSell
Peter C. FarrellDirector2026-09-02970$234.73
$227.69kSell
Michael J. FarrellCEO;Chair2026-08-074,991$146.34
$730.38kBuy
Michael J. FarrellCEO;Chair2026-08-074,991$205.69
$1.03MSell
Peter C. FarrellDirector2026-08-058,000$225.00
$1.80MSell
Michael J. FarrellChairman and CEO2026-07-074,991$146.34
$730.38kBuy
Michael J. FarrellChairman and CEO2026-07-074,991$218.55
$1.09MSell

1 of 6

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Christopher G. Roberts1.18%1,700,337$406.33MInsider
Michael A. 1. Quinn0.89%1,277,650$305.32MInsider
Peter C. Farrell0.76%1,095,977$261.91MInsider
Gary W. Pace0.46%666,236$159.21MInsider
Michael J. Farrell0.34%496,113$118.56MInsider
Curated Wealth Partners LLC0.21%297,057$70.99MInstitution
Robert Andrew Douglas0.18%264,375$63.18MInsider
David Pendarvis0.06%89,729$21.44MInsider
Anne Reiser0.06%84,633$20.22MInsider
Brett Sandercock0.06%83,495$19.95MInsider

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD0.07%4.33%Net SellingNet Selling
ALC0.05%0.00%
WST0.10%3.91%Net SellingNet Selling
MDLN0.06%93.17%Net SellingNet Selling
BDX0.10%0.74%Net SellingNet Selling

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 0.07% institutional shareholders, 4.33% Resmed insiders, and 95.60% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.18% of the company. Christopher G. Roberts's Resmed shares are currently valued at $406.33M.

If you're new to stock investing, here's how to buy Resmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.